We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $299M Turnover 13.67%
1-Year Est. Return 53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
Cap. Flow
+$8.26M
Cap. Flow %
2.77%
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held Equity + Options
3.4 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
2.3 years
Avg Time Held Equity only
3.4 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
2.3 years

Top Buys

Rank Stock Value
1
FHLC icon
Fidelity MSCI Health Care Index ETF
FHLC
+$18.3M
2
SIBN icon
SI-BONE Inc
SIBN
+$3.79M
3
DUOT icon
Duos Technologies
DUOT
+$2.91M
4
APGE icon
Apogee Therapeutics
APGE
+$2.91M
5
NPCE icon
Neuropace
NPCE
+$1.61M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$9.41M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.14M
3
ANAB icon
AnaptysBio
ANAB
+$3.29M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$1.64M
5
PIPR icon
Piper Sandler
PIPR
+$1.27M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.9%
2 Healthcare 21.84%
3 Technology 4.77%
4 Financials 3.58%
5 Industrials 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TRV icon
26
Travelers Companies
TRV
$82.5B
$1.85M 0.62%
5,606
+31
+0.6% +$9.4K
2019 Q4
26 quarters
MSFT icon
27
Microsoft
MSFT
$3.95T
$1.75M 0.59%
4,684
+178
+4% +$72K
2019 Q4
26 quarters
HCAT icon
28
Health Catalyst
HCAT
$132M
$1.73M 0.58%
871,082
-32,000
-4% -$46.2K
2020 Q2
24 quarters
MMM icon
29
3M
MMM
$88.4B
$1.58M 0.53%
9,733
-28
-0.3% -$4.24K
2019 Q4
26 quarters
IJJ icon
30
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.58B
$1.48M 0.49%
9,998
+724
+8% +$102K
2020 Q4
22 quarters
CRNX icon
31
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.44M 0.48%
38,595
+18,100
+88% +$673K
2023 Q4
10 quarters
IWN icon
32
iShares Russell 2000 Value ETF
IWN
$13.7B
$1.43M 0.48%
6,475
+455
+8% +$95.2K
2025 Q2
4 quarters
XENE icon
33
Xenon Pharmaceuticals
XENE
$3.51B
$1.39M 0.47%
23,000
– –
2024 Q1
9 quarters
IVE icon
34
iShares S&P 500 Value ETF
IVE
$50.2B
$1.34M 0.45%
5,909
+167
+3% +$37.3K
2020 Q4
22 quarters
TSLA icon
35
Tesla
TSLA
$1.48T
$1.19M 0.4%
2,834
+1
+0% +$398
2019 Q4
26 quarters
XEL icon
36
Xcel Energy
XEL
$47.9B
$1.05M 0.35%
13,138
+68
+0.5% +$5.43K
2019 Q4
26 quarters
LQD icon
37
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$28.9B
$1.02M 0.34%
9,335
+337
+4% +$36.7K
2025 Q2
4 quarters
USB icon
38
US Bancorp
USB
$92.1B
$1.01M 0.34%
16,643
-326
-2% -$18.3K
2019 Q4
26 quarters
VTI icon
39
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
$919K 0.31%
2,482
+7
+0.3% +$2.5K
2019 Q4
26 quarters
AGG icon
40
iShares Core US Aggregate Bond ETF
AGG
$138B
$914K 0.31%
9,230
+179
+2% +$17.7K
2022 Q3
15 quarters
HSBC icon
41
HSBC
HSBC
$317B
$857K 0.29%
9,008
– –
2019 Q4
26 quarters
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$820B
$807K 0.27%
1,081
-41
-4% -$29.7K
2019 Q4
26 quarters
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.16T
$784K 0.26%
2,193
+167
+8% +$60.1K
2019 Q4
26 quarters
PG icon
44
Procter & Gamble
PG
$370B
$764K 0.26%
5,210
+72
+1% +$10.5K
2019 Q4
26 quarters
AMZN icon
45
Amazon
AMZN
$2.83T
$711K 0.24%
2,983
+148
+5% +$37.1K
2019 Q4
26 quarters
SPEM icon
46
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$695K 0.23%
13,425
-1,567
-10% -$80.1K
2019 Q4
26 quarters
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$2.23B
$597K 0.2%
35,196
– –
2021 Q2
20 quarters
ECL icon
48
Ecolab
ECL
$80.8B
$585K 0.2%
2,101
+6
+0.3% +$1.58K
2019 Q4
26 quarters
MO icon
49
Altria Group
MO
$125B
$568K 0.19%
7,889
+121
+2% +$8.44K
2019 Q4
26 quarters
JTEK icon
50
JPMorgan US Tech Leaders ETF
JTEK
$4.5B
$567K 0.19%
5,085
+3,359
+195% +$333K
2024 Q1
9 quarters
1
2
3 4 5

Similar funds

GWM
Glass Wealth Management San Antonio, Texas $299M AUM 66.9% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
SC
Sawyer & Company Boston, Massachusetts $298M AUM 31.71% 1-Year Est. Return
ACC
Acorn Creek Capital Fort Collins, Colorado $299M AUM 23.67% 1-Year Est. Return
AIM
Avanda Investment Management Singapore $299M AUM 50.34% 1-Year Est. Return
SEM
Strategic Equity Management Tucson, Arizona $298M AUM 27.02% 1-Year Est. Return
SIIL
Sinvest Investments II Ltd Nassau, New Providence $298M AUM
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

HighMark Wealth Management's Q2 2026 Portfolio in Review

As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

  • HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
  • HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
  • HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
  • HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
  • HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
  • HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.